Funding cuts to medical research pose an immediate threat to the health and safety of patients participating in clinical studies.As financial resources dwindle, critical oversight mechanisms such as Institutional Review Boards (IRBs) struggle to maintain their essential functions, jeopardizing the ethical conduct of research.